Glaucoma care is shifting gears, and Glaukos is driving the change.
At ESCRS 2025, the conversation around interventional glaucoma is louder than ever, with the European launch of the iStent infinite® marking a major milestone. Designed for patients with moderate to advanced open-angle glaucoma, this next-generation trabecular micro-bypass technology is redefining what early and effective intervention looks like. But this story isn’t just about tools. It’s about mindset. Hear from the experts behind Glaukos—Joseph Gilliam and Andrew Geddes—as they discuss innovation, investment and the movement toward proactive glaucoma management.
